Treace Medical Concepts (TMCI) Scheduled to Post Earnings on Tuesday

Treace Medical Concepts (NASDAQ:TMCI) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.30) per share for the quarter. Treace Medical Concepts has set its FY 2024 guidance at EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

Treace Medical Concepts (NASDAQ:TMCI) last posted its quarterly earnings data on Tuesday, February 27th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.01). Treace Medical Concepts had a negative return on equity of 33.96% and a negative net margin of 26.47%. The firm had revenue of $62.20 million for the quarter, compared to analyst estimates of $60.56 million. During the same period in the prior year, the company earned ($0.08) earnings per share. The firm’s quarterly revenue was up 24.9% on a year-over-year basis. On average, analysts expect Treace Medical Concepts to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Treace Medical Concepts Stock Performance

Shares of TMCI opened at $10.65 on Tuesday. The stock has a market capitalization of $657.74 million, a price-to-earnings ratio of -13.15 and a beta of 0.27. Treace Medical Concepts has a 12 month low of $5.27 and a 12 month high of $27.70. The firm has a fifty day simple moving average of $12.45 and a 200 day simple moving average of $11.69. The company has a current ratio of 4.40, a quick ratio of 3.76 and a debt-to-equity ratio of 0.38.

About Treace Medical Concepts

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.